Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with multiple myeloma (MM):
- People who have been diagnosed with multiple myeloma
- People who are 18 years of age or older
- People who are currently receiving treatment for multiple myeloma (at any stage of treatment — first, second, or third line or beyond) at a Hematology Unit
- People who speak Italian fluently
For caregivers:
- People whose close family member or loved one with multiple myeloma has already taken part in the first part of this study
- People who are the main unpaid caregiver for that person (for example, a family member or close friend providing regular support)
- People who are 18 years of age or older
- People who speak Italian fluently
Who may not be able to join:
For people with multiple myeloma (MM):
- People who have other health conditions that would make it difficult to participate, such as dementia or a severe psychiatric disorder
For caregivers:
- No specific exclusion criteria have been listed for caregivers (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0039 0522 522416
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Health related quality of life (HRQoL); Health related quality of life (HRQoL); Participation; Reactions to caring; 5. Self-efficacy; Open-ended questions of a semi-structured interview that was written by researchers and clinicians and with the support of expert individuals with MM and their caregivers to collect the disease-related experiences and its consequences on daily life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.